Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Roger J. Packer"'
Autor:
Nicole J. Ullrich, Stewart Goldman, Jeffrey C. Allen, Mark W. Kieran, Nathan Robison, Sanjay P. Prabhu, David H. Gutmann, Michael Fisher, Bruce R. Korf, David Viskochil, Roger J. Packer, John P. Perentesis
Publikováno v:
Pediatric Blood & Cancer. 68
Data for visual acuity (VA) after treatment of neurofibromatosis type 1-associated optic pathway gliomas (NF1-OPGs) are limited. We retrospectively collected VA, converted to logMAR, before and after targeted therapy with everolimus for NF1-OPG, and
Autor:
John P. Perentesis, Michael Fisher, Sanjay P. Prabhu, Stewart Goldman, Nicole J. Ullrich, Bruce R. Korf, Nathan Robison, Jeffrey C. Allen, Mark W. Kieran, Roger J. Packer, David H. Gutmann, David Viskochil
Data for visual acuity (VA) after treatment of neurofibromatosis type 1-associated optic pathway gliomas (NF1-OPGs) is limited. We retrospectively collected VA, converted to logMAR, before and after targeted therapy with everolimus for NF1-OPG, and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77be2b463c55926a5d2cc8d4fa21135e
https://doi.org/10.22541/au.160257425.59424784/v1
https://doi.org/10.22541/au.160257425.59424784/v1
Autor:
Nicole J. Ullrich, Allison A. King, Leslie L. Robison, Kimberly Whelan, Roger J. Packer, Joseph P. Neglia, Kristy Seidel, Kevin R. Krull, Elizabeth Wells, Gregory T. Armstrong, Marilyn Stovall, Wendy M. Leisenring, Kevin C. Oeffinger, Charles A. Sklar, Lisa Diller
Publikováno v:
Neuro-Oncology. 20:132-142
Background Survivors of childhood central nervous system (CNS) tumors experience high rates of treatment-related neurologic sequelae. Whether survivors continue to be at increased risk for new events as they age is unknown. Methods Adverse neurologic
Autor:
Michael Fisher, Brigitte C. Widemann, Bruce R. Korf, Grant T. Liu, James A. Katowitz, Kelly A. Hutcheson, Robert Listernick, Roger J. Packer, Eva Dombi, William P. Madigan, Gena Heidary, Robert A. Avery, Jerry E. Berland, Edmond J. FitzGibbon
Publikováno v:
Ophthalmology. 124:123-132
Topic Children and adults with neurofibromatosis type 1 (NF1), a common autosomal dominant condition, manifest a variety of ophthalmologic conditions. Plexiform neurofibromas (PNs) involving the eyelid, orbit, periorbital, and facial structures (orbi
Autor:
Azra H. Ligon, Lindsay Kilburn, Tina Young Poussaint, Ibrahim Qaddoumi, Maryam Fouladi, Michael Fisher, Regina I. Jakacki, Gilbert Vezina, Malcolm G. Smith, Neal I. Lindeman, Clinton F. Stewart, Zoltan Patay, Ashok Panigrahy, David T.W. Jones, Ira J. Dunkel, Patricia Baxter, Stewart Goldman, Girish Dhall, Susa G Kreissman, Sofia Haque, Austin Doyle, Roger J. Packer, David S. Enterline, Jason Fangusaro, Arzu Onar-Thomas, Paul G. Fisher, Jeremy Jones, Blaise V. Jones, Soonme Cha, Benita Tamrazi, Anu Banerjee, Shengjie Wu, Ian F. Pollack, Stefan M. Pfister, Jessica S Stern
BACKGROUND: Pediatric low-grade glioma (pLGG) is the most common CNS tumor of childhood. Progression-free survival (PFS) is much lower than overall survival emphasizing the need for alternative treatments. In addition, many children suffer functional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31771c9b6d67fa5d3818908638233aa9
https://europepmc.org/articles/PMC6477212/
https://europepmc.org/articles/PMC6477212/
Autor:
Girish Dhall, Laurence Austin Doyle, Lindsay Kilburn, Soonmee Cha, Sofia Haque, Susan G. Kreissman, David S. Enterline, Ira J. Dunkel, Roger J. Packer, Jason Fangusaro, Clinton F. Stewart, Zoltan Patay, Maryam Fouladi, David T.W. Jones, Shengjie Wu, Ashok Panigrahy, Michael Fisher, Ibrahim Qaddoumi, Patricia Baxter, Regina I. Jakacki, Benita Tamrazi, Neal I. Lindeman, Azra H. Ligon, Anuradha Banerjee, Stewart Goldman, Tina Young Poussaint, Arzu Onar-Thomas, Malcolm A. Smith, Ian F. Pollack, Stefan M. Pfister, Gilbert Vezina, Paul G. Fisher, Jeremy Jones, Jessica S Stern
Publikováno v:
The Lancet. Oncology, vol 20, iss 7
Lancet Oncol
Lancet Oncol
BACKGROUND: Pediatric low-grade glioma (pLGG) is the most common central nervous system tumor of childhood. Although overall survival is very good, many children suffer from multiple progressions and functional morbidities. There is no one universall
Autor:
Linda Heier, Amar Gajjar, Jeff M. Michalski, Peter C. Burger, Eugene Hwang, Ian F. Pollack, Alok Jaju, Yimei Li, Catherine A. Billups, Roger J. Packer, Paul A. Northcott, James M. Olson, Kyle S. Smith, Maryam Fouladi, Sarah Leary
Publikováno v:
Neuro-Oncology
BACKGROUND Metastasis, residual disease, and diffuse anaplasia are high-risk features in medulloblastoma. METHODS This was a randomized phase 3 study. Patients age 3–21 years with high-risk medulloblastoma received (+/-) daily carboplatin with 36Gy
Autor:
Michael Fisher, Nicole J. Ullrich, Lloyd J. Edwards, Matthias A. Karajannis, Jeffrey C. Allen, Jaishri O. Blakeley, Scott R. Plotkin, Bruce R. Korf, Wade Clapp, Gary Cutter, Roger J. Packer, Jian Campian, Girish Dhall, James H. Tonsgard, Coretta Thomas
Publikováno v:
Neuro Oncol
BACKGROUND Bevacizumab treatment at 2.5–5 mg/kg/week is associated with hearing improvement and tumor shrinkage in about 40% of patients with neurofibromatosis 2 (NF2) and progressive vestibular schwannomas (VS). Treatment-emergent hypertension and
Autor:
Roger J. Packer, Elizabeth M. Wells
Publikováno v:
CONTINUUM: Lifelong Learning in Neurology. 21:373-396
Pediatric brain tumors differ from those arising in adulthood. This article discusses the presentation, location, histology, new molecular understanding, therapy, and outcome of brain tumors in children.Improved biological understanding of pediatric
Autor:
Jason Fangusaro, Shengjie Wu, Arie Perry, Joanna J. Phillips, Stewart Goldman, Clinton F. Stewart, Ibrahim Qaddoumi, Theodore Nicolaides, Roger J. Packer, Tina Young Poussaint, Larry E. Kun, Anuradha Banerjee, Regina I. Jakacki, Michael D. Prados, James M. Boyett, Ian F. Pollack, Lawrence A. Doyle, Arzu Onar-Thomas, Maryam Fouladi, David C. Turner, Sridharan Gururangan
Publikováno v:
Neuro-oncology, vol 19, iss 8
Background Activation of the mitogen-activated protein kinase pathway is important for growth of pediatric low-grade gliomas (LGGs). The aim of this study was to determine the recommended phase II dose (RP2D) and the dose-limiting toxicities (DLTs) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759c2ecb2acbd5073e7c2e3898b5161a
https://escholarship.org/uc/item/5vd9v7sb
https://escholarship.org/uc/item/5vd9v7sb